171 related articles for article (PubMed ID: 28138510)
1. Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition.
Vemuri P; Lowe VJ; Knopman DS; Senjem ML; Kemp BJ; Schwarz CG; Przybelski SA; Machulda MM; Petersen RC; Jack CR
Alzheimers Dement (Amst); 2017; 6():21-30. PubMed ID: 28138510
[TBL] [Abstract][Full Text] [Related]
2. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal tau PET in ageing and Alzheimer's disease.
Jack CR; Wiste HJ; Schwarz CG; Lowe VJ; Senjem ML; Vemuri P; Weigand SD; Therneau TM; Knopman DS; Gunter JL; Jones DT; Graff-Radford J; Kantarci K; Roberts RO; Mielke MM; Machulda MM; Petersen RC
Brain; 2018 May; 141(5):1517-1528. PubMed ID: 29538647
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.
Lowe VJ; Bruinsma TJ; Wiste HJ; Min HK; Weigand SD; Fang P; Senjem ML; Therneau TM; Boeve BF; Josephs KA; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Neurology; 2019 Jul; 93(1):e29-e39. PubMed ID: 31147421
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer's Disease.
Qiao Z; Wang G; Zhao X; Wang K; Fan D; Chen Q; Ai L
Front Aging Neurosci; 2022; 14():841942. PubMed ID: 35663582
[TBL] [Abstract][Full Text] [Related]
6. Tau PET With
Huang CC; Hsiao IT; Huang CY; Weng YC; Huang KL; Liu CH; Chang TY; Wu HC; Yen TC; Lin KJ
Front Neurol; 2019; 10():503. PubMed ID: 31191427
[No Abstract] [Full Text] [Related]
7. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
[TBL] [Abstract][Full Text] [Related]
8. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
[TBL] [Abstract][Full Text] [Related]
9. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults.
McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
[TBL] [Abstract][Full Text] [Related]
11. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
[TBL] [Abstract][Full Text] [Related]
12. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
13. Tau Positron-Emission Tomography in Former National Football League Players.
Stern RA; Adler CH; Chen K; Navitsky M; Luo J; Dodick DW; Alosco ML; Tripodis Y; Goradia DD; Martin B; Mastroeni D; Fritts NG; Jarnagin J; Devous MD; Mintun MA; Pontecorvo MJ; Shenton ME; Reiman EM
N Engl J Med; 2019 May; 380(18):1716-1725. PubMed ID: 30969506
[TBL] [Abstract][Full Text] [Related]
14. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
[TBL] [Abstract][Full Text] [Related]
15. The effect of β-amyloid positivity on cerebral metabolism in cognitively normal seniors.
Bozoki AC; Zdanukiewicz M; Zhu DC;
Alzheimers Dement; 2016 Dec; 12(12):1250-1258. PubMed ID: 27445158
[TBL] [Abstract][Full Text] [Related]
16. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
17. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.
Mishra S; Gordon BA; Su Y; Christensen J; Friedrichsen K; Jackson K; Hornbeck R; Balota DA; Cairns NJ; Morris JC; Ances BM; Benzinger TLS
Neuroimage; 2017 Nov; 161():171-178. PubMed ID: 28756238
[TBL] [Abstract][Full Text] [Related]
18. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.
Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Lowe VJ; Graff-Radford J; Roberts RO; Mielke MM; Machulda MM; Petersen RC; Jack CR
Ann Neurol; 2017 Nov; 82(5):706-718. PubMed ID: 29023983
[TBL] [Abstract][Full Text] [Related]
19. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
20. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.
Smith R; Wibom M; Pawlik D; Englund E; Hansson O
JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
